These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24782261)

  • 41. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-Cell Immunity against the Hepatitis C Virus: A Persistent Research Priority in an Era of Highly Effective Therapy.
    Smith S; Honegger JR; Walker C
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 32205413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.
    Li D; Wang X; von Schaewen M; Tao W; Zhang Y; Heller B; Hrebikova G; Deng Q; Sun Q; Ploss A; Zhong J; Huang Z
    J Infect Dis; 2017 Jun; 215(12):1824-1831. PubMed ID: 28398489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
    Fafi-Kremer S; Fauvelle C; Felmlee DJ; Zeisel MB; Lepiller Q; Fofana I; Heydmann L; Stoll-Keller F; Baumert TF
    Viruses; 2012 Oct; 4(10):2016-30. PubMed ID: 23202451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A virological perspective on the need for vaccination.
    Locarnini S
    J Viral Hepat; 2000 May; 7 Suppl 1():5-6. PubMed ID: 10866836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic vaccines against hepatitis C virus.
    Xue J; Zhu H; Chen Z
    Infect Genet Evol; 2014 Mar; 22():120-9. PubMed ID: 24462908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
    Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
    Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research?
    Rosen HR
    Hepatology; 2017 Jan; 65(1):341-349. PubMed ID: 27640881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
    Callendret B; Eccleston HB; Hall S; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
    Hepatology; 2014 Nov; 60(5):1531-40. PubMed ID: 24975498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.
    Hahn JA; Wylie D; Dill J; Sanchez MS; Lloyd-Smith JO; Page-Shafer K; Getz WM
    Epidemics; 2009 Mar; 1(1):47-57. PubMed ID: 20445816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.
    Weiland O; Ahlén G; Diepolder H; Jung MC; Levander S; Fons M; Mathiesen I; Sardesai NY; Vahlne A; Frelin L; Sällberg M
    Mol Ther; 2013 Sep; 21(9):1796-805. PubMed ID: 23752314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
    Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
    J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Designing an HCV vaccine: a unique convergence of prevention and therapy?
    Walker CM
    Curr Opin Virol; 2017 Apr; 23():113-119. PubMed ID: 28550816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
    Lin Y; Kwon T; Polo J; Zhu YF; Coates S; Crawford K; Dong C; Wininger M; Hall J; Selby M; Coit D; Medina-Selby A; McCoin C; Ng P; Drane D; Chien D; Han J; Vajdy M; Houghton M
    J Virol; 2008 Aug; 82(15):7492-503. PubMed ID: 18508900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
    Klade CS; Wedemeyer H; Berg T; Hinrichsen H; Cholewinska G; Zeuzem S; Blum H; Buschle M; Jelovcan S; Buerger V; Tauber E; Frisch J; Manns MP
    Gastroenterology; 2008 May; 134(5):1385-95. PubMed ID: 18471515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virus-Specific Cellular Response in Hepatitis C Virus Infection.
    Kaźmierczak J; Caraballo Cortes K; Bukowska-Ośko I; Radkowski M
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):101-10. PubMed ID: 26429740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune system control of hepatitis C virus infection.
    Stuart JD; Salinas E; Grakoui A
    Curr Opin Virol; 2021 Feb; 46():36-44. PubMed ID: 33137689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C vaccines: Inducing and challenging memory T cells.
    Shiina M; Rehermann B
    Hepatology; 2006 Jun; 43(6):1395-8. PubMed ID: 16729320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.